CV Sciences (CVSI) Operating Expenses (2011 - 2026)
CV Sciences (CVSI) posted Operating Expenses of $1.9 million for Q1 2026, up 169.04% sequentially from -$2.7 million in Q4 2025, and up 89.9% YoY from $990000.0 in Q1 2025.
CV Sciences (CVSI) Operating Expenses (2011 - 2026) Analysis & Trends
CV Sciences has reported Operating Expenses for 16 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Operating Expenses rose 89.9% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 54.24% YoY) and the FY2025 annual result came in at $3.3 million, down 65.0% from the prior year.
- Operating Expenses climbed to $1.9 million in Q1 2026 per CVSI's latest filing, from -$2.7 million in the prior quarter.
- Over five years, Operating Expenses peaked at $3.7 million in Q4 2022 and troughed at -$3.4 million in Q4 2023.
- A 5-year average of $1.7 million and a median of $2.3 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 168.85% in 2024, then slumped 217.22% in 2025.
- Over 5 years, Operating Expenses stood at $3.7 million in 2022, then sank by 191.51% to -$3.4 million in 2023, then jumped by 168.85% to $2.3 million in 2024, then plunged by 217.22% to -$2.7 million in 2025, then jumped by 169.04% to $1.9 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.9 million, -$2.7 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | CV Sciences | 4.12 Mn | 3.86 Mn | 1.45 Mn | 1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | -2.72 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 990,000.00 |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 769,000.00 |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | -3.37 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 2.79 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 3.69 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 2.67 Mn |
| Dec 31, 2021 | 10.45 Mn |
| Sep 30, 2021 | 5.34 Mn |